| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Neuroendocrinology (A.Fö., I.H.M., K.J.K.), Institute of Experimental Medicine, H-1083 Budapest, Hungary; Department of Genetics, Cell, and Immunobiology (A.K.F., E.B., K.H., A.Fa.) and 3rd Department of Internal Medicine (L.R., M.K.), Semmelweis University, H-1089 Budapest, Hungary; Samuel Lunenfeld Research Institute (A.N.), Mount Sinai Hospital, Toronto, Canada M5G 1X5; and Molecular Immunology Research Group (A.Fa.), Hungarian Academy of Sciences, H-1089 Budapest, Hungary
Address all correspondence and requests for reprints to: Krisztina J. Kovács, Ph.D., Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Szigony u. 43, H-1083 Budapest, Hungary. E-mail: kovacs{at}koki.hu.
Histamine has been referred to as an anorexic factor that decreases appetite and fat accumulation and affects feeding behavior. Tuberomammillary histaminergic neurons have been implicated in central mediation of peripheral metabolic signals such as leptin, and centrally released histamine inhibits ob gene expression. Here we have characterized the metabolic phenotype of mice that completely lack the ability to produce histamine because of targeted disruption of the key enzyme in histamine biosynthesis (histidine decarboxylase, HDC). Histochemical analyses confirmed the lack of HDC mRNA, histamine immunoreactivity, and histaminergic innervation throughout the brain of gene knockout mouse. Aged histamine-deficient (HDC-/-) mice are characterized by visceral adiposity, increased amount of brown adipose tissue, impaired glucose tolerance, hyperinsulinemia, and hyperleptinemia. Histamine-deficient animals are not hyperphagic but gain more weight and are calorically more efficient than wild-type controls. These metabolic changes presumably are due to the impaired regulatory loop between leptin and hypothalamic histamine that results in orexigenic dominance through decreased energy expenditure, attenuated ability to induce uncoupling protein-1 mRNA in the brown adipose tissue and defect in mobilizing energy stores. Our results further support the role of histamine in regulation of energy homeostasis.
This article has been cited by other articles:
![]() |
H. L. Haas, O. A. Sergeeva, and O. Selbach Histamine in the Nervous System Physiol Rev, July 1, 2008; 88(3): 1183 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yoshimoto, Y. Miyamoto, K. Shimamura, A. Ishihara, K. Takahashi, H. Kotani, A. S. Chen, H. Y. Chen, D. J. MacNeil, A. Kanatani, et al. Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus PNAS, September 12, 2006; 103(37): 13866 - 13871. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Musio, B. Gallo, S. Scabeni, M. Lapilla, P. L. Poliani, G. Matarese, H. Ohtsu, S. J. Galli, R. Mantegazza, L. Steinman, et al. A Key Regulatory Role for Histamine in Experimental Autoimmune Encephalomyelitis: Disease Exacerbation in Histidine Decarboxylase-Deficient Mice J. Immunol., January 1, 2006; 176(1): 17 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Masaki, S. Chiba, T. Yasuda, H. Noguchi, T. Kakuma, T. Watanabe, T. Sakata, and H. Yoshimatsu Involvement of Hypothalamic Histamine H1 Receptor in the Regulation of Feeding Rhythm and Obesity Diabetes, September 1, 2004; 53(9): 2250 - 2260. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |